Chris van Ingen, president of Agilent’s Bio-Analytical Measurement business, will retire on Oct. 31, the last day of the company’s fiscal year, Agilent announced last month. Van Ingen, 61, has been at Agilent and Hewlett Packard, which Agilent was originally part of, for 30 years. He joined HP in 1977 as a sales engineer in the Netherlands and was appointed to his current position in May 2001. No replacement has been named.
Lumera said this week that Ulf Jonsson, former CEO of Biacore, and Jim Richey, CEO of Auguron Biosciences, have joined the board of directors of Plexera Bioscience, its recently created proteomics subsidiary.
Jonsson was one of the three founders of Biacore, which spun out of Pharmacia Biosensor in 1987. GE Healthcare acquired Biacore in 2006
Richey is co-founder, president, and CEO of Auguron Biosciences, a protein array spin out of Harvard Medical School. He has held senior executive positions in several biotechnology firms including LJL BioSystems (acquired by Molecular Devices), PerSeptive BioSystems (acquired by Applied Biosystems), Pharmacia Biosensor (acquired by GE Healthcare), and Pharmacia Biotech (acquired by Amersham).